CivicGraph — Due Diligence Pack

GlaxoSmithKline Plc

ABN 60089509544company • Generated 2026-03-24
Executive Summary
  • Receives $3.8M in tracked government funding and contracts.
  • Flagged: has both political donations and government contracts — cross-reference recommended.
Entity Type
company
State
NSW
SEIFA DecileSocio-Economic Indexes for Areas — decile 1 is most disadvantaged, 10 is least
9
Community Ctrl
No
Remoteness
Major Cities of Australia
LGA
Ryde
Integrity Flag:This entity has both political donation records and government contract records. Cross-reference recommended.
Financial Summary

No ACNC financial data on file — this entity may not be a registered charity, or financials have not yet been lodged.

Government Funding

No government funding records found — clean record in tracked datasets.

Government Contracts
Total Value
$3.8M
Contracts
1
TitleValueBuyerStart
4500111061$3.8MDepartment of Health and Aged Care27 June 2013
Political Connections
Total Donations
$26K
Records
6
Party / RecipientTotal
Casey Business Briefing Club$13K
Liberal Party of Australia (Victorian Division)$9K
Progressive Business Association Inc$4K
Evidence Alignment (ALMAAustralian Living Map of Alternatives — JusticeHub's evidence database of what works)

No evidence-backed programs (ALMA) linked yet — this entity may operate programs not yet catalogued in the Australian Living Map of Alternatives.

Geographic Context
Locality
BLENHEIM ROAD
Remoteness
Major Cities of Australia
Local Ecosystem
837 orgs
Integrity Assessment
ABN registered
ACNC financials available
Evidence-backed programs (ALMA)
Government funding received
Government contracts held
No political donations
No donations + contracts overlap
Serves disadvantaged area
Data Sources & Citation
CivicGraph Due Diligence Pack: GlaxoSmithKline Plc (ABN 60089509544). Generated 2026-03-24. Data sources: CivicGraph Entity Graph, ACNC, AusTender, AEC, ALMA.
CivicGraph — Decision Infrastructure for Government & Social Sector

This due diligence pack is auto-generated from public data sources. Verify critical claims against primary sources before inclusion in formal submissions.